Correlation Between Phio Pharmaceuticals and Merus BV

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Phio Pharmaceuticals and Merus BV at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Phio Pharmaceuticals and Merus BV into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Phio Pharmaceuticals Corp and Merus BV, you can compare the effects of market volatilities on Phio Pharmaceuticals and Merus BV and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Phio Pharmaceuticals with a short position of Merus BV. Check out your portfolio center. Please also check ongoing floating volatility patterns of Phio Pharmaceuticals and Merus BV.

Diversification Opportunities for Phio Pharmaceuticals and Merus BV

0.13
  Correlation Coefficient

Average diversification

The 3 months correlation between Phio and Merus is 0.13. Overlapping area represents the amount of risk that can be diversified away by holding Phio Pharmaceuticals Corp and Merus BV in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Merus BV and Phio Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Phio Pharmaceuticals Corp are associated (or correlated) with Merus BV. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Merus BV has no effect on the direction of Phio Pharmaceuticals i.e., Phio Pharmaceuticals and Merus BV go up and down completely randomly.

Pair Corralation between Phio Pharmaceuticals and Merus BV

Given the investment horizon of 90 days Phio Pharmaceuticals Corp is expected to under-perform the Merus BV. In addition to that, Phio Pharmaceuticals is 2.48 times more volatile than Merus BV. It trades about -0.1 of its total potential returns per unit of risk. Merus BV is currently generating about -0.06 per unit of volatility. If you would invest  5,487  in Merus BV on August 24, 2024 and sell it today you would lose (1,051) from holding Merus BV or give up 19.15% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Phio Pharmaceuticals Corp  vs.  Merus BV

 Performance 
       Timeline  
Phio Pharmaceuticals Corp 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Phio Pharmaceuticals Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's forward indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm investors.
Merus BV 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Merus BV has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in December 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Phio Pharmaceuticals and Merus BV Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Phio Pharmaceuticals and Merus BV

The main advantage of trading using opposite Phio Pharmaceuticals and Merus BV positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Phio Pharmaceuticals position performs unexpectedly, Merus BV can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Merus BV will offset losses from the drop in Merus BV's long position.
The idea behind Phio Pharmaceuticals Corp and Merus BV pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.

Other Complementary Tools

Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity